Research


October 11, 2021

UAMS Cancer Researcher Brian Koss, Ph.D., is First in State to Earn Prestigious NIH Director’s Award

Marty Trieschmann

Brian Koss, Ph.D., a researcher with the UAMS Winthrop P. Rockefeller Cancer Institute, is the state’s first recipient of the prestigious National Institutes of Health (NIH) Director’s Early Independence Award.

LITTLE ROCK — Brian Koss, Ph.D., a researcher with the UAMS Winthrop P. Rockefeller Cancer Institute, is the state’s first recipient of the prestigious National Institutes of Health (NIH) Director’s Early Independence Award.


August 25, 2021

NIH Awards UAMS’ Nakagawa $3.6 Million to Expand HPV Cancer Vaccine Study

Marty Trieschmann

Dr. Mayumi Nakagawa - With an additional $3.6 million from the National Institutes of Health, Mayumi Nakagawa's, M.D., Ph.D., ground-breaking HPV vaccine research tops $10 million.

Mayumi Nakagawa, M.D., Ph.D., was awarded $3.6 million from the National Cancer Institute (NCI) to complete phase 2 clinical trials of PepCan, a breakthrough vaccine she developed at UAMS to treat cancers caused by human papillomavirus (HPV).


August 19, 2021

UAMS Researcher Leading $3.1 Million Preschool Intervention to Reduce Obesity and Cancer in Arkansas, Louisiana

David Robinson

Taren Swindle, Ph.D., here visiting a Head Start classroom in 2019, is leading the NCI-funded study that aims to improve diets in early care and education settings.

UAMS is leading a major new effort to reduce cancer by addressing eating habits in early childcare and education settings. The project, led by UAMS’ Taren Swindle, Ph.D., will reach about 5,000 children and 500 teachers across Arkansas and Louisiana.


July 21, 2021

Cancer Discovery Published in Nature Highlights National Role of UAMS Research Team

David Robinson

Members of the UAMS proteomics team are Alan Tackett, Ph.D. (center front), and (l-r) Stephanie Byrum, Ph.D., Rick Edmondson, Ph.D., Aaron Storey, Ph.D., and Samuel Mackintosh, Ph.D.

LITTLE ROCK — A highly specialized UAMS research team that serves as a national resource recently helped the University of North Carolina (UNC) discover a key driver of cancer cell development. The discovery, which gives researchers around the globe a new target for drug therapies, was published in the journal Nature. The achievement put an…


June 24, 2021

UAMS’ First Phase 1 Cancer Clinical Trial Testing New Way to Protect Hearts while Treating Cancer

David Robinson

UAMS' Hui-Ming Chang, M.D., is leading the Phoenix Trial.

LITTLE ROCK — The drug dexrazoxane has a reputation akin to someone who both fights and sets fires. On the one hand, this Food and Drug Administration (FDA)-approved drug prevents heart damage caused by doxorubicin, which is used in chemotherapy. On the other hand, dexrazoxane may undermine the cancer treatment, causing many doctors to leave…


June 1, 2021

Jenkins to Help Lead Clinical Trials Expansion at UAMS Winthrop P. Rockefeller Cancer Institute

Linda Haymes

Amy Jo Jenkins, M.S., CCRP, leads Early Phase Clinical Trials in the UAMS Winthrop P. Rockefeller Cancer Institute’s new Office of Clinical Trials Administration.

LITTLE ROCK — Amy Jo Jenkins, M.S., CCRP, recently joined the Winthrop P. Rockefeller Cancer Institute’s new Office of Clinical Trials Administration and will lead the Early Phase Clinical Trials at the University of Arkansas for Medical Sciences (UAMS).


May 11, 2021

UAMS Cancer Researcher Hong-yu Li, Ph.D., Awarded $1.27 Million Grant

Linda Haymes

Hong-yu Li, Ph.D.

LITTLE ROCK — Hong-yu Li, Ph.D., a researcher with the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS), recently received a five-year, $1,265,834 grant from the National Institutes of Health and the National Cancer Institute to work toward developing treatment options for acute myeloid leukemia patients. Li, a professor…


April 20, 2021

UAMS Cancer Researcher Receives $1.1 Million as Part of NIH Grant at University of Arkansas, Fayetteville

David Robinson

Isabelle Racine Miousse, Ph.D., is studying the role of a common nutrient in cancer in cancer treatment.

A National Institutes of Health (NIH) grant will allow UAMS researcher Isabelle Racine Miousse, Ph.D., to ramp up her study of a nutrient that may have a role in the effectiveness of immunotherapy for cancer patients. Miousse will receive $220,000 per year for up to five years as one of four project leaders at the…


April 12, 2021

Cancer DNA Blood Tests Validated By International Research Team

News Staff

UAMS' Donald Johann Jr., M.D., was part of an international team of researchers that conducted an independent assessment of five commercially-available assays for tumor DNA sequencing. The team's findings were published in the journal Nature Biotechnology.

LITTLE ROCK — An international team today reports the findings of an independent assessment of five commercially-available assays for tumor DNA sequencing – a fast, cheap and less invasive method to diagnose and monitor cancer.


April 6, 2021

UAMS Researchers Named Arkansas Research Alliance Scholar, Fellow

Susan Van Dusen

Edward T.H. Yeh, M.D., (left) and Alan Tackett, Ph.D., have been honored by the Arkansas Research Alliance (ARA). The group named Yeh an ARA Scholar and Tackett an ARA Fellow.

LITTLE ROCK — The Arkansas Research Alliance (ARA) announced today that two researchers at the University of Arkansas for Medical Sciences will be joining their ranks.



Next page